Investment Overview MSMM believes Catalyst Pharmaceuticals (Nasdaq: CPRX $2.88) is a good swing-move for the remainder of November of 2018. The company has a PDUFA action date on November 28th … [Read more...] about CPRX Swing Move For November 2018
Swing Trades
Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath
2 ACRX Insiders Sold For Massive Gains, 4 others Bought and Held-Shareholders Turn is Next
Tuesday October 16th, 2018 AcelRx Pharmaceuticals (NASDAQ: ACRX) Chief Development Officer (CDO) and Chief Engineer reported selling an aggregate of 33,567 shares at $5 per share. The month before the … [Read more...] about 2 ACRX Insiders Sold For Massive Gains, 4 others Bought and Held-Shareholders Turn is Next
ACRX Update-Strong Hold
We did indeed call the swing. ACRX was trading at around$2.90 when we identified it as a good swing-trade candidate. Currently it is trading around $4.54 making for a healthy 55% gain. Where I was … [Read more...] about ACRX Update-Strong Hold
ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It
MS Money Moves Swing thesis for AcelRX Pharma (ACRX) published last week in our "Swing Alert"article played out nicely. ACRX spiked ~70% from $2.90 to $4.92 in the last 5 trading sessions. The upward … [Read more...] about ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It
ACRX Stay the course
Premarket today TRVN has dropped almost 70% off news that the FDA believes their drug Oliceridine has high abuse potential. With ACRX's ADCOM this week too I can understand the hesitation to … [Read more...] about ACRX Stay the course